201 related articles for article (PubMed ID: 30726501)
1. Impacts of a Brazilian pharmaceutical program on the health of chronic patients.
Almeida ATC; Sá EB; Vieira FS; Benevides RPSE
Rev Saude Publica; 2019 Jan; 53():20. PubMed ID: 30726501
[TBL] [Abstract][Full Text] [Related]
2. [The list of drugs in the Popular Pharmacy Program and the Brazilian National Pharmaceutical Care Policy].
Yamauti SM; Barberato-Filho S; Lopes LC
Cad Saude Publica; 2015 Aug; 31(8):1648-62. PubMed ID: 26375644
[TBL] [Abstract][Full Text] [Related]
3. "Farmácia Popular do Brasil" Program: characterization and evolution between 2004 and 2012.
da Silva RM; Caetano R
Cien Saude Colet; 2015 Oct; 20(10):2943-56. PubMed ID: 26465839
[TBL] [Abstract][Full Text] [Related]
4. Free access to hypertension and diabetes medicines among the elderly: a reality yet to be constructed.
Paniz VM; Fassa AG; Facchini LA; Piccini RX; Tomasi E; Thumé E; da Silveira DS; Rodrigues MA; Domingues MR; Bertoldi AD
Cad Saude Publica; 2010 Jun; 26(6):1163-74. PubMed ID: 20657981
[TBL] [Abstract][Full Text] [Related]
5. [Sources of medicines for chronic patients using the Brazilian Unified National Health System].
Matta SR; Bertoldi AD; Emmerick ICM; Fontanella AT; Costa KS; Luiza VL;
Cad Saude Publica; 2018 Mar; 34(3):e00073817. PubMed ID: 29590242
[TBL] [Abstract][Full Text] [Related]
6. Access to medicines in the Brazilian Unified Health System's primary health care: assessment of a public policy.
Barbosa MM; Moreira TA; Nascimento RC; Nascimento MM; Acurcio FA; Godman B; Guerra AA; Alvares-Teodoro J
J Comp Eff Res; 2021 Jul; 10(10):869-879. PubMed ID: 34032143
[TBL] [Abstract][Full Text] [Related]
7. Equity analysis of resource distribution for the Popular Pharmacy Program.
Silva MELE; Almeida ATC; Araújo Júnior IT
Rev Saude Publica; 2019 May; 53():50. PubMed ID: 31116239
[TBL] [Abstract][Full Text] [Related]
8. Analysis of hospital dental care for patients with special needs in Brazil.
Vivacqua ABG; Lucena EHG; Pucca Júnior GA; Martins FC
Braz Oral Res; 2024; 38():e007. PubMed ID: 38747816
[TBL] [Abstract][Full Text] [Related]
9. Nutritional status coverage trend registered in the SISVAN web in seven municipalities of the Zona Da Mata Mineira, Brazil, from 2008 to 2017, and its association with socio-economic, demographic and organisation of health system variables.
Gonçalves IDSA; Pereira PF; Silva MBL; Ladeira FB; Moreira TR; Cotta RMM; da Costa GD
J Nutr Sci; 2020 Jan; 9():e4. PubMed ID: 32042412
[TBL] [Abstract][Full Text] [Related]
10. [Hospitalizations for primary care-sensitive conditions in a Southern Brazilian municipality].
Rodrigues-Bastos RM; Campos EM; Ribeiro LC; Firmino RU; Bustamante-Teixeira MT
Rev Assoc Med Bras (1992); 2013; 59(2):120-7. PubMed ID: 23582552
[TBL] [Abstract][Full Text] [Related]
11. Malpractice and socioeconomic aspects in neurosurgery: a developing-country reality.
de Macêdo Filho LJM; Aragão ACA; Moura IA; Olivier LB; Albuquerque LAF
Neurosurg Focus; 2020 Nov; 49(5):E13. PubMed ID: 33130629
[TBL] [Abstract][Full Text] [Related]
12. Brazilian generics market change after Farmácia Popular program.
Bertoldi AD; Chaves LA; Ross-Degnan D; Luiza VL; Emmerick ICM; Silva RMD; Campos MR
Rev Saude Publica; 2019; 53():94. PubMed ID: 31644724
[TBL] [Abstract][Full Text] [Related]
13. Availability of essential medicines in primary health care of the Brazilian Unified Health System.
Nascimento RCRMD; Álvares J; Guerra AA; Gomes IC; Costa EA; Leite SN; Costa KS; Soeiro OM; Guibu IA; Karnikowski MGO; Acurcio FA
Rev Saude Publica; 2017 Nov; 51(suppl 2):10s. PubMed ID: 29160448
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the selection of medicines for the Brazilian primary health care.
Karnikowski MGO; Galato D; Meiners MMMA; Silva EVD; Gerlack LF; Bós ÂJG; Leite SN; Álvares J; Guibu IA; Soeiro OM; Costa KS; Costa EA; Guerra AA; Acurcio FA
Rev Saude Publica; 2017 Nov; 51(suppl 2):9s. PubMed ID: 29160450
[TBL] [Abstract][Full Text] [Related]
15. [Sources of medicines for hypertension and diabetes in Brazil: telephone survey results from Brazilian state capitals and the Federal District, 2011].
Costa KS; Francisco PM; Malta DC; Barros MB
Cad Saude Publica; 2016 Feb; 32(2):e00090014. PubMed ID: 26910253
[TBL] [Abstract][Full Text] [Related]
16. Medicine prices and availability in the Brazilian Popular Pharmacy Program.
Pinto Cdu B; Miranda ES; Emmerick IC; Costa Ndo R; Castro CG
Rev Saude Publica; 2010 Aug; 44(4):611-9. PubMed ID: 20585741
[TBL] [Abstract][Full Text] [Related]
17. [The "Farmácia Popular do Brasil" Program and aspects of public provision of medicines in Brazil].
Santos-Pinto Cdu B; Costa Ndo R; Osorio-de-Castro CG
Cien Saude Colet; 2011 Jun; 16(6):2963-73. PubMed ID: 21709993
[TBL] [Abstract][Full Text] [Related]
18. [National pharmaceutical policy in Colombia and social security reform: access and rational use of medicines].
Mejia Restrepo S; Velez Arango AL; Buritica Arboleda OC; Arango Mejia MC; Rio Gomez JA
Cad Saude Publica; 2002; 18(4):1025-39. PubMed ID: 12118308
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of visceral leishmaniasis reports by the capture-recapture method].
Maia-Elkhoury AN; Carmo EH; Sousa-Gomes ML; Mota E
Rev Saude Publica; 2007 Dec; 41(6):931-7. PubMed ID: 18066464
[TBL] [Abstract][Full Text] [Related]
20. Strategies to improve the availability of medicines in primary health care in Brazil: findings and implications.
Barbosa MM; Nascimento RC; Garcia MM; Acurcio FA; Godman B; Guerra AA; Alvares-Teodoro J
J Comp Eff Res; 2021 Feb; 10(3):243-253. PubMed ID: 33541125
[No Abstract] [Full Text] [Related]
[Next] [New Search]
